Taxol-dependent mutants of Chinese hamster ovary cells with alterations in alpha- and beta-tubulin

doi:10.1083/jcb.102.4.1522

This Article

	Full Text (PDF, 1283K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JCB
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Schibler, M. J.
	Articles by Cabral, F.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Schibler, M. J.
	Articles by Cabral, F.


Social Bookmarking

	What's this?

ARTICLES

Taxol-dependent mutants of Chinese hamster ovary cells with alterations in alpha- and beta-tubulin

MJ Schibler and F Cabral

Chinese hamster ovary cell mutants resistant to the microtubule stabilizing drug taxol were isolated in a single step. Of these 139 drug-resistant mutants, 59 exhibit an absolute requirement for taxol for normal growth and division, 13 have a partial requirement, and 69 grow normally without the drug. Two-dimensional gel analysis of whole cell proteins reveal "extra" spots representing altered tubulins in 13 of the mutants. Six of these have an altered alpha-tubulin and seven have an altered beta-tubulin. Cells with an absolute dependence on taxol become large and multinucleated when deprived of the drug. In contrast, partially dependent cells exhibit some multinucleation, but most cells appear normal. In one mutant that has an absolute dependence on taxol, the cells appear to die more quickly and their nuclei do not increase in size or number. As previously found for another taxol- dependent mutant (Cabral, F., 1983, J. Cell. Biol., 97:22-29), the taxol dependence of the mutants described in this paper behaves recessively in somatic cell hybrids, and the cells are more susceptible to being killed by colcemid than are the wild-type parental cells. When compared with wild-type cells, taxol-dependent mutants have normal arrays of cytoplasmic microtubules but form much smaller mitotic spindles in the presence of taxol. When deprived of the drug, however, these mutants cannot complete assembly of the mitotic spindle apparatus, as judged by tubulin immunofluorescence. Thus, the defects leading to taxol dependence in these mutants with defined alterations in alpha- and beta-tubulin appear to result from the cell's inability to form a functional mitotic spindle. Reversion analysis indicates that the properties of at least one alpha-tubulin mutant are conferred by the altered tubulin seen on two-dimensional gels.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Yin, S., Cabral, F., Veeraraghavan, S. (2007). Amino acid substitutions at proline 220 of {beta}-tubulin confer resistance to paclitaxel and colcemid. Molecular Cancer Therapeutics 6: 2798-2806 [Abstract] [Full Text]
Yang, C.-P. H., Verdier-Pinard, P., Wang, F., Lippaine-Horvath, E., He, L., Li, D., Hofle, G., Ojima, I., Orr, G. A., Horwitz, S. B. (2005). A highly epothilone B-resistant A549 cell line with mutations in tubulin that confer drug dependence. Molecular Cancer Therapeutics 4: 987-995 [Abstract] [Full Text]
Loganzo, F., Hari, M., Annable, T., Tan, X., Morilla, D. B., Musto, S., Zask, A., Kaplan, J., Minnick, A. A. Jr., May, M. K., Ayral-Kaloustian, S., Poruchynsky, M. S., Fojo, T., Greenberger, L. M. (2004). Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in {alpha}-tubulin. Molecular Cancer Therapeutics 3: 1319-1327 [Abstract] [Full Text]
Ling, X., Bernacki, R. J., Brattain, M. G., Li, F. (2004). Induction of Survivin Expression by Taxol (Paclitaxel) Is an Early Event, Which Is Independent of Taxol-mediated G2/M Arrest. J. Biol. Chem. 279: 15196-15203 [Abstract] [Full Text]
Martello, L. A., Verdier-Pinard, P., Shen, H.-J., He, L., Torres, K., Orr, G. A., Horwitz, S. B. (2003). Elevated Levels of Microtubule Destabilizing Factors in a Taxol-resistant/dependent A549 Cell Line with an {alpha}-Tubulin Mutation. Cancer Res. 63: 1207-1213 [Abstract] [Full Text]
Hari, M., Wang, Y., Veeraraghavan, S., Cabral, F. (2002). Mutations in {alpha}- and {beta}-Tubulin That Stabilize Microtubules and Confer Resistance to Colcemid and Vinblastine. Molecular Cancer Therapeutics 2: 597-605 [Abstract] [Full Text]
Barlow, S. B., Gonzalez-Garay, M. L., Cabral, F. (2002). Paclitaxel-dependent mutants have severely reduced microtubule assembly and reduced tubulin synthesis. J. Cell Sci. 115: 3469-3478 [Abstract] [Full Text]
Sale, S., Sung, R., Shen, P., Yu, K., Wang, Y., Duran, G. E., Kim, J.-H., Fojo, T., Oefner, P. J., Sikic, B. I. (2002). Conservation of the Class I {beta}-Tubulin Gene in Human Populations and Lack of Mutations in Lung Cancers and Paclitaxel-resistant Ovarian Cancers. Molecular Cancer Therapeutics 1: 215-225 [Abstract] [Full Text]
Nicoletti, M. I., Valoti, G., Giannakakou, P., Zhan, Z., Kim, J.-H., Lucchini, V., Landoni, F., Mayo, J. G., Giavazzi, R., Fojo, T. (2001). Expression of {beta}-Tubulin Isotypes in Human Ovarian Carcinoma Xenografts and in a Sub-Panel of Human Cancer Cell Lines from the NCI-Anticancer Drug Screen: Correlation with Sensitivity to Microtubule Active Agents. Clin. Cancer Res. 7: 2912-2922 [Abstract] [Full Text]
Vredenburg, M. R., Ojima, I., Veith, J., Pera, P., Kee, K., Cabral, F., Sharma, A., Kanter, P., Greco, W. R., Bernacki, R. J. (2001). Effects of Orally Active Taxanes on P-Glycoprotein Modulation and Colon and Breast Carcinoma Drug Resistance. JNCI J Natl Cancer Inst 93: 1234-1245 [Abstract] [Full Text]
Legault, J., Gaulin, J.-F., Mounetou, E., Bolduc, S., Lacroix, J., Poyet, P., C.-Gaudreault, R. (2000). Microtubule Disruption Induced in Vivo by Alkylation of {beta}-Tubulin by 1-Aryl-3- (2-Chloroethyl)Ureas, a Novel Class of Soft Alkylating Agents. Cancer Res. 60: 985-992 [Abstract] [Full Text]
Gonzalez-Garay, M. L., Chang, L., Blade, K., Menick, D. R., Cabral, F. (1999). A beta -Tubulin Leucine Cluster Involved in Microtubule Assembly and Paclitaxel Resistance. J. Biol. Chem. 274: 23875-23882 [Abstract] [Full Text]
Zeng, L., Baird, Wm. V. (1999). Inheritance of resistance to anti-microtubule dinitroaniline herbicides in an ""intermediate"" resistant biotype of Eleusine indica (Poaceae). Am. J. Bot. 86: 940-947 [Abstract] [Full Text]
Monzo, M., Rosell, R., Sanchez, J. J., Lee, J. S., O'Brate, A., Gonzalez-Larriba, J. L., Alberola, V., Lorenzo, J. C., Nunez, L., Ro, J. Y., Martin, C. (1999). Paclitaxel Resistance in Non-Small-Cell Lung Cancer Associated With Beta-Tubulin Gene Mutations. JCO 17: 1786-1786 [Abstract] [Full Text]
D'Andrea, G., Fennelly, D., Norton, L., Baselga, J., Gilewski, T., Hudis, C., Moynahan, M. E., Raptis, G., Sklarin, N., Surbone, A., Theodoulou, M., Templeton, M. A., Yao, T.-J., Seidman, A. D. (1999). Phase I Study of Escalating Doses of Edatrexate in Combination with Paclitaxel in Patients with Metastatic Breast Cancer. Clin. Cancer Res. 5: 275-279 [Abstract] [Full Text]
Blade, K, Menick, D., Cabral, F (1999). Overexpression of class I, II or IVb beta-tubulin isotypes in CHO cells is insufficient to confer resistance to paclitaxel. J. Cell Sci. 112: 2213-2221 [Abstract]
Giannakakou, P., Sackett, D. L., Kang, Y.-K., Zhan, Z., Buters, J. T.�M., Fojo, T., Poruchynsky, M. S. (1997). Paclitaxel-resistant Human Ovarian Cancer Cells Have Mutant beta -Tubulins That Exhibit Impaired Paclitaxel-driven Polymerization. J. Biol. Chem. 272: 17118-17125 [Abstract] [Full Text]
Lam, Y. F., Chan, C. J., Kuhn, J. G (1997). Review : Pharmacokinetics and pharmacodynamics of the taxanes. J Oncol Pharm Pract 3: 76-93 [Abstract]